The goal of this program project is elucidate the mechanisms of angiogenic regulation by bringing together a unique collection of experienced investigators to integrate their multiple approaches, systems and modes of analysis. Outlined in this application are six projects designed to identify the biological signals that guide capillary growth and to analyze their mechanisms of action. These projects will use biochemical, molecular, morphological, cellular, immunocytochemical, and pharmacological methods of investigation both in vivo and in vitro. Project I will apply molecular biological methods to analyze the regulation of basic and acidic FGF (heparin-binding growth factor) gene expression. Project II will analyze the process by which capillary endothelial cell growth is controlled locally by extracellular matrix with special emphasis on mechanisms of signal transduction. Project III will use in vitro and in vivo methods to characterize the mechanisms and developmental role of EC-pericyte interactions in microvascular growth control. Project IV will investigate the molecular and cellular relationships amongst tumor cells, mast cells and endothelial cells in tumor angiogenesis. Project V will elucidate mechanisms of angiogenic regulation by determining the role played in the normal vascularization of avascular cartilage by mast cells, pericytes and angiogenic factors. Project VI will examine the mechanisms, biological effects, and therapeutic potential of angiogenesis inhibitors in vitro and in vivo. Through this approach we plan to define the principles of angiogenic regulation at the molecular, cellular and tissue levels.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Cancer Special Program Advisory Committee (CAK)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Children's Hospital Boston
United States
Zip Code
Adapala, R K; Thoppil, R J; Ghosh, K et al. (2016) Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy. Oncogene 35:314-22
Pelton, Kristine; Coticchia, Christine M; Curatolo, Adam S et al. (2014) Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo. Am J Pathol 184:2099-110
German, Alexandra E; Mammoto, Tadanori; Jiang, Elisabeth et al. (2014) Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression. J Cell Sci 127:1672-83
Ingber, Donald E; Wang, Ning; Stamenovic, Dimitrije (2014) Tensegrity, cellular biophysics, and the mechanics of living systems. Rep Prog Phys 77:046603
Roy, R; Zurakowski, D; Wischhusen, J et al. (2014) Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. Br J Cancer 111:1772-9
Procaccia, Vera; Nakayama, Hironao; Shimizu, Akio et al. (2014) Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility. Biochem Biophys Res Commun 448:134-8
Battinelli, Elisabeth M; Markens, Beth A; Kulenthirarajan, Rajesh A et al. (2014) Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response. Blood 123:101-12
Li, Wenliang; Ai, Nanping; Wang, Suming et al. (2014) GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proc Natl Acad Sci U S A 111:1521-6
Gee, Elaine P S; YĆ¼ksel, Deniz; Stultz, Collin M et al. (2013) SLLISWD sequence in the 10FNIII domain initiates fibronectin fibrillogenesis. J Biol Chem 288:21329-40
Baek, Kwan-Hyuck; Bhang, Dongha; Zaslavsky, Alexander et al. (2013) Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. J Clin Invest 123:4375-89

Showing the most recent 10 out of 277 publications